Fairbanks leader Cross stepping down after impressive run
When Helene Cross arrived to lead Fairbanks Addiction Treatment Center in 2001, the alcohol and drug rehabilitation hospital was as sick financially as its patients were physically.
Health Care & Life Sciences
Articles
Doctors, hospitals follow only parts of Regenstrief’s IT prescription
The great results Regenstrief Institute has produced over the years in studies at Indianapolis’ Wishard Memorial Hospital have not held up when conducted in a wider variety of settings.
Bristol-Myers to buy former Lilly partner Amylin for $5.3B
Bristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment to Eli Lilly and Co. of about $1.7 billion.
Q&A
The U.S. Supreme Court’s ruling to uphold the Patient Protection & Affordable Care Act cleared a big cloud of uncertainty for employers, but with just 18 months before the most significant provisions of the law kick in, many questions remain. Three benefits consultants from Indianapolis-based Gregory & Appel Insurance—Bob Miller, Mike Miles and Karl Ahlrichs—sat down to discuss what the future looks like for employer health benefits.
High court health care decision good for some, not others
The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to boost many players in the health care industry, but not every corner of the sector will benefit.
Daniels says legislators to decide Medicaid change
Indiana Gov. Mitch Daniels says he wants to make sure he understands the Supreme Court ruling upholding the health care law before deciding how the state will respond.
High court ruling opens Medicaid escape hatch for states
While upholding President Obama’s health care law, the U.S. Supreme Court may have created a way out for states that do not want to expand their Medicaid programs. Whether Indiana decides to opt out remains to be seen.
High court ruling could leave 290K Hoosiers uncovered
A decision by Indiana to leave its Medicaid program unchanged could leave as many as 290,000 Hoosier adults, who would have been newly eligible for Medicaid coverage, with no good options.
Insurance stocks sink, hospital shares rise after ruling
Stocks of hospital companies rose sharply and insurance companies fell Thursday after the Supreme Court upheld a requirement that almost all Americans carry health insurance. WellPoint shares were down more than 5 percent.
U.S. health-care overhaul upheld by Supreme Court
The U.S. Supreme Court has upheld the core of President Barack Obama’s health-care overhaul, preserving most of a law that would expand insurance to millions of people and transform an industry that makes up 18 percent of the nation’s economy.
Indiana awaits ruling before starting health exchange
Indiana has spent the past year and a half planning for its own health insurance exchange in case the U.S. Supreme Court upholds President Barack Obama's health care law, but the state still could end up being forced into the federal exchange.
Covance plans $150M expansion, 465 jobs in Greenfield
The New Jersey-based pharmaceutical research company is seeking state and local incentives as part of the expansion, which would include a new laboratory, set to be finished in 2016. Covance already employs 565 workers at the site.
Electronic health records bring $135M to Indiana
The federal stimulus program to speed “meaningful use” of electronic medical records is starting to generate significant cash for Indiana health care providers: More than $135 million has flowed to more than 2,000 Hoosier hospitals and doctors since January 2011.
Life sciences hold up in recession
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
Analysis: How stocks will fare in ruling on health care law
The Supreme Court is expected to rule on the Affordable Care Act by the end of June. Here’s a roundup of how health care businesses would be affected under four different scenarios.
Notre Dame receives $5M for adult stem cell research
The university says the gift from an alumnus will fund three new endowed professorships in adult and all forms of non-embryonic stem cell research, in hopes of accelerating discovery of new treatments for heart disease, diabetes and some cancers.
Indiana smoking ban brings new sign rules
To comply with the statewide smoking ban that begins July 1, there's more for businesses to do than stop patrons and employees from smoking indoors. The same law compels businesses to post an array of signs that announce the ban.
J&J, Bayer fail to win U.S. OK for expanded Xarelto use
If approved for acute coronary syndrome, Xarelto would compete with Effient from Indianapolis-based Eli Lilly and Co and Brilinta from London-based AstraZeneca Plc.
Medical startup plans 71 jobs, seeks incentives
The city of Indianapolis granted preliminary approval for an eight-year tax abatement to Arcamed Inc., which plans to purchase $1.4 million in equipment to design and manufacture titanium and case-tray systems for surgical instruments.
Lilly resumes $3B stock buyback program, declares dividend
The local pharmaceutical giant plans to complete the program started in 2000 by repurchasing $420 million in shares by the end of the year. And on Tuesday, it declared a regular dividend of 49 cents.